Concepts (212)
Concepts are derived automatically from a person's publications.
Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.
| Name | Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
|---|
| Vascular Endothelial Growth Factor A | 14 | 2023 | 3511 | 1.570 |
Why?
|
| Neovascularization, Physiologic | 9 | 2021 | 1351 | 1.360 |
Why?
|
| Peptides | 4 | 2023 | 4410 | 0.840 |
Why?
|
| Pancreatic Elastase | 1 | 2020 | 136 | 0.740 |
Why?
|
| Acute Lung Injury | 1 | 2023 | 380 | 0.680 |
Why?
|
| Peptide Fragments | 3 | 2021 | 5096 | 0.630 |
Why?
|
| Angiogenesis Inducing Agents | 4 | 2017 | 282 | 0.630 |
Why?
|
| Pulmonary Emphysema | 1 | 2020 | 672 | 0.510 |
Why?
|
| Ischemia | 2 | 2021 | 1907 | 0.490 |
Why?
|
| Up-Regulation | 1 | 2020 | 4222 | 0.390 |
Why?
|
| Colitis, Ulcerative | 1 | 2023 | 1911 | 0.380 |
Why?
|
| Proteoglycans | 3 | 2014 | 836 | 0.380 |
Why?
|
| Disease Models, Animal | 8 | 2023 | 18034 | 0.350 |
Why?
|
| rhoB GTP-Binding Protein | 2 | 2013 | 16 | 0.350 |
Why?
|
| Melanocytes | 3 | 2020 | 515 | 0.330 |
Why?
|
| Laminin | 1 | 2008 | 419 | 0.300 |
Why?
|
| Neovascularization, Pathologic | 7 | 2014 | 2638 | 0.280 |
Why?
|
| Endothelial Cells | 8 | 2020 | 3486 | 0.270 |
Why?
|
| Signal Transduction | 5 | 2021 | 23406 | 0.250 |
Why?
|
| Glycoproteins | 1 | 2012 | 2266 | 0.240 |
Why?
|
| Antigens, CD | 2 | 2012 | 4026 | 0.240 |
Why?
|
| Alkyl and Aryl Transferases | 1 | 2003 | 89 | 0.230 |
Why?
|
| Leishmaniasis, Visceral | 1 | 2003 | 94 | 0.210 |
Why?
|
| Mice, Inbred C57BL | 13 | 2021 | 21833 | 0.190 |
Why?
|
| Collagen | 1 | 2008 | 2688 | 0.180 |
Why?
|
| Peptide Hydrolases | 1 | 2023 | 634 | 0.180 |
Why?
|
| Endothelium, Vascular | 4 | 2013 | 4458 | 0.180 |
Why?
|
| Mice | 21 | 2023 | 81202 | 0.180 |
Why?
|
| Myocardial Infarction | 1 | 2021 | 11718 | 0.180 |
Why?
|
| Mice, Inbred C3H | 1 | 2020 | 964 | 0.170 |
Why?
|
| Severe Acute Respiratory Syndrome | 1 | 2020 | 137 | 0.170 |
Why?
|
| Vascular Endothelial Growth Factor Receptor-2 | 2 | 2020 | 547 | 0.170 |
Why?
|
| Negative-Pressure Wound Therapy | 2 | 2011 | 150 | 0.170 |
Why?
|
| Smoke | 1 | 2020 | 227 | 0.170 |
Why?
|
| Rats | 4 | 2023 | 24252 | 0.160 |
Why?
|
| Pulmonary Alveoli | 1 | 2020 | 675 | 0.150 |
Why?
|
| Capillary Permeability | 3 | 2016 | 798 | 0.150 |
Why?
|
| Animals | 24 | 2023 | 168770 | 0.150 |
Why?
|
| Neuropilin-2 | 1 | 2016 | 54 | 0.140 |
Why?
|
| Cytokines | 2 | 2023 | 7323 | 0.140 |
Why?
|
| Fibroblast Growth Factor 2 | 2 | 2008 | 599 | 0.140 |
Why?
|
| Apoptosis | 5 | 2020 | 9726 | 0.130 |
Why?
|
| Skin Pigmentation | 2 | 2014 | 282 | 0.130 |
Why?
|
| Micelles | 1 | 2015 | 203 | 0.120 |
Why?
|
| Angiogenesis Inhibitors | 3 | 2010 | 2038 | 0.120 |
Why?
|
| Nerve Degeneration | 1 | 2018 | 748 | 0.120 |
Why?
|
| Neuropilin-1 | 1 | 2014 | 90 | 0.120 |
Why?
|
| Dendritic Cells | 2 | 2020 | 2725 | 0.120 |
Why?
|
| Enzyme-Linked Immunosorbent Assay | 3 | 2014 | 3873 | 0.120 |
Why?
|
| Albinism, Oculocutaneous | 1 | 2013 | 17 | 0.110 |
Why?
|
| Interleukin-6 | 1 | 2023 | 3203 | 0.110 |
Why?
|
| Monophenol Monooxygenase | 1 | 2013 | 69 | 0.110 |
Why?
|
| Cells, Cultured | 7 | 2018 | 19233 | 0.110 |
Why?
|
| Liver Regeneration | 1 | 2014 | 210 | 0.110 |
Why?
|
| Extracellular Matrix Proteins | 2 | 2014 | 850 | 0.110 |
Why?
|
| Protein Binding | 2 | 2017 | 9384 | 0.110 |
Why?
|
| Perfusion | 1 | 2017 | 1360 | 0.110 |
Why?
|
| Chemokine CCL2 | 1 | 2014 | 619 | 0.100 |
Why?
|
| Wound Healing | 3 | 2013 | 2785 | 0.100 |
Why?
|
| Lymphangiogenesis | 1 | 2013 | 174 | 0.100 |
Why?
|
| Polyesters | 2 | 2015 | 363 | 0.100 |
Why?
|
| Corneal Neovascularization | 1 | 2013 | 188 | 0.100 |
Why?
|
| Proto-Oncogene Proteins | 1 | 2003 | 4554 | 0.100 |
Why?
|
| Extracellular Matrix | 1 | 2018 | 1741 | 0.100 |
Why?
|
| Blotting, Western | 3 | 2014 | 5181 | 0.090 |
Why?
|
| Drug Carriers | 1 | 2015 | 693 | 0.090 |
Why?
|
| Lactic Acid | 1 | 2015 | 1132 | 0.090 |
Why?
|
| Rats, Sprague-Dawley | 1 | 2021 | 8300 | 0.090 |
Why?
|
| Kruppel-Like Transcription Factors | 1 | 2013 | 504 | 0.090 |
Why?
|
| Acetylglucosamine | 1 | 2011 | 191 | 0.090 |
Why?
|
| Polyethylene Glycols | 1 | 2015 | 1182 | 0.090 |
Why?
|
| Lymphedema | 1 | 2016 | 534 | 0.090 |
Why?
|
| Intestine, Small | 1 | 2015 | 1240 | 0.080 |
Why?
|
| Multipotent Stem Cells | 1 | 2010 | 186 | 0.080 |
Why?
|
| Ventricular Function, Left | 1 | 2021 | 3666 | 0.080 |
Why?
|
| Epidermis | 1 | 2011 | 528 | 0.080 |
Why?
|
| Cyclohexanes | 1 | 2008 | 152 | 0.080 |
Why?
|
| Polymers | 1 | 2015 | 1621 | 0.080 |
Why?
|
| Proto-Oncogene Proteins c-akt | 2 | 2009 | 2504 | 0.080 |
Why?
|
| Skin | 2 | 2011 | 4371 | 0.080 |
Why?
|
| Thrombospondin 1 | 1 | 2009 | 250 | 0.080 |
Why?
|
| Sesquiterpenes | 1 | 2008 | 177 | 0.070 |
Why?
|
| Computer Simulation | 1 | 2020 | 6194 | 0.070 |
Why?
|
| Inflammation | 3 | 2023 | 10636 | 0.070 |
Why?
|
| Hyperoxia | 1 | 2009 | 262 | 0.070 |
Why?
|
| Doxycycline | 1 | 2008 | 326 | 0.070 |
Why?
|
| Retinal Diseases | 1 | 2013 | 684 | 0.070 |
Why?
|
| Dexamethasone | 2 | 2010 | 1951 | 0.070 |
Why?
|
| NF-kappa B | 2 | 2014 | 2499 | 0.070 |
Why?
|
| Immunohistochemistry | 3 | 2014 | 11366 | 0.060 |
Why?
|
| Hemangioma | 1 | 2010 | 738 | 0.060 |
Why?
|
| Cell Proliferation | 5 | 2013 | 10484 | 0.060 |
Why?
|
| Diabetes Complications | 1 | 2011 | 1359 | 0.060 |
Why?
|
| Farnesyltranstransferase | 1 | 2003 | 76 | 0.060 |
Why?
|
| Retina | 2 | 2018 | 2616 | 0.060 |
Why?
|
| Cadherins | 1 | 2008 | 907 | 0.060 |
Why?
|
| Nerve Tissue Proteins | 1 | 2016 | 4464 | 0.060 |
Why?
|
| Retinal Vessels | 1 | 2009 | 772 | 0.060 |
Why?
|
| Drug Combinations | 1 | 2008 | 1958 | 0.060 |
Why?
|
| Cell Movement | 3 | 2013 | 5218 | 0.060 |
Why?
|
| Regeneration | 1 | 2011 | 1485 | 0.050 |
Why?
|
| Neoplastic Stem Cells | 1 | 2010 | 1376 | 0.050 |
Why?
|
| Coronavirus Infections | 1 | 2020 | 3135 | 0.050 |
Why?
|
| Active Transport, Cell Nucleus | 1 | 2003 | 443 | 0.050 |
Why?
|
| Pneumonia, Viral | 1 | 2020 | 3242 | 0.050 |
Why?
|
| Lung | 1 | 2020 | 9857 | 0.050 |
Why?
|
| Granulation Tissue | 2 | 2011 | 93 | 0.050 |
Why?
|
| Glucocorticoids | 1 | 2010 | 2108 | 0.050 |
Why?
|
| Israel | 1 | 2003 | 796 | 0.050 |
Why?
|
| Pandemics | 1 | 2020 | 8386 | 0.040 |
Why?
|
| Cornea | 1 | 2008 | 1524 | 0.040 |
Why?
|
| Membrane Proteins | 1 | 2016 | 7882 | 0.040 |
Why?
|
| Female | 7 | 2021 | 380200 | 0.040 |
Why?
|
| Endometriosis | 1 | 2007 | 839 | 0.040 |
Why?
|
| Nerve Crush | 1 | 2018 | 78 | 0.040 |
Why?
|
| Administration, Oral | 3 | 2015 | 3914 | 0.040 |
Why?
|
| Early Growth Response Protein 1 | 1 | 2018 | 138 | 0.040 |
Why?
|
| Wounds and Injuries | 1 | 2011 | 2400 | 0.040 |
Why?
|
| Liver | 1 | 2014 | 7475 | 0.040 |
Why?
|
| Tissue Inhibitor of Metalloproteinase-1 | 1 | 2018 | 149 | 0.040 |
Why?
|
| Cell Membrane | 1 | 2008 | 3749 | 0.040 |
Why?
|
| Flow Cytometry | 1 | 2008 | 5974 | 0.040 |
Why?
|
| Anti-Inflammatory Agents, Non-Steroidal | 1 | 2008 | 2282 | 0.040 |
Why?
|
| Optic Nerve Injuries | 1 | 2018 | 150 | 0.040 |
Why?
|
| Phosphorylation | 3 | 2018 | 8437 | 0.040 |
Why?
|
| Mice, Inbred BALB C | 2 | 2016 | 6387 | 0.040 |
Why?
|
| Specific Pathogen-Free Organisms | 1 | 2016 | 226 | 0.040 |
Why?
|
| Melanoma | 2 | 2012 | 5511 | 0.030 |
Why?
|
| Humans | 16 | 2020 | 744376 | 0.030 |
Why?
|
| Antineoplastic Agents | 2 | 2010 | 13695 | 0.030 |
Why?
|
| Proto-Oncogene Proteins c-fos | 1 | 2018 | 575 | 0.030 |
Why?
|
| Matrix Metalloproteinase 9 | 1 | 2018 | 638 | 0.030 |
Why?
|
| Animals, Newborn | 2 | 2013 | 2726 | 0.030 |
Why?
|
| Caco-2 Cells | 1 | 2015 | 387 | 0.030 |
Why?
|
| Cell Nucleus | 1 | 2003 | 2969 | 0.030 |
Why?
|
| Pigmentation | 1 | 2014 | 148 | 0.030 |
Why?
|
| Intestinal Absorption | 1 | 2015 | 420 | 0.030 |
Why?
|
| Reverse Transcriptase Polymerase Chain Reaction | 2 | 2011 | 4751 | 0.030 |
Why?
|
| Neuroglia | 1 | 2018 | 928 | 0.030 |
Why?
|
| Sequence Homology, Nucleic Acid | 1 | 2014 | 1085 | 0.030 |
Why?
|
| Disease Susceptibility | 1 | 2020 | 1782 | 0.030 |
Why?
|
| Retinal Ganglion Cells | 1 | 2018 | 770 | 0.030 |
Why?
|
| Blotting, Northern | 1 | 2014 | 1581 | 0.030 |
Why?
|
| Lymphatic Vessels | 1 | 2016 | 353 | 0.030 |
Why?
|
| Neuroprotective Agents | 1 | 2018 | 941 | 0.030 |
Why?
|
| Crosses, Genetic | 1 | 2013 | 791 | 0.030 |
Why?
|
| Nanofibers | 1 | 2011 | 66 | 0.020 |
Why?
|
| Occlusive Dressings | 1 | 2011 | 50 | 0.020 |
Why?
|
| Skin Neoplasms | 1 | 2010 | 5692 | 0.020 |
Why?
|
| Endocytosis | 1 | 2015 | 985 | 0.020 |
Why?
|
| Blood Vessels | 1 | 2016 | 1125 | 0.020 |
Why?
|
| Tensile Strength | 1 | 2011 | 335 | 0.020 |
Why?
|
| In Situ Hybridization | 1 | 2014 | 1950 | 0.020 |
Why?
|
| Hemangioma, Capillary | 1 | 2010 | 61 | 0.020 |
Why?
|
| Mice, Inbred Strains | 1 | 2013 | 1828 | 0.020 |
Why?
|
| Microcirculation | 1 | 2014 | 1287 | 0.020 |
Why?
|
| Transforming Growth Factor beta1 | 1 | 2013 | 644 | 0.020 |
Why?
|
| Proto-Oncogene Proteins c-fyn | 1 | 2009 | 116 | 0.020 |
Why?
|
| Gene Expression Regulation | 2 | 2020 | 12073 | 0.020 |
Why?
|
| Thrombospondins | 1 | 2009 | 198 | 0.020 |
Why?
|
| Mutation | 1 | 2013 | 29786 | 0.020 |
Why?
|
| Oxygen | 2 | 2011 | 4189 | 0.020 |
Why?
|
| Immunity, Innate | 1 | 2020 | 2962 | 0.020 |
Why?
|
| Adherens Junctions | 1 | 2008 | 90 | 0.020 |
Why?
|
| Neoplastic Syndromes, Hereditary | 1 | 2010 | 241 | 0.020 |
Why?
|
| Carcinoma, Lewis Lung | 1 | 2008 | 114 | 0.020 |
Why?
|
| Hypersensitivity, Delayed | 1 | 2008 | 484 | 0.020 |
Why?
|
| Genetic Linkage | 1 | 2013 | 2421 | 0.020 |
Why?
|
| Survival Analysis | 1 | 2020 | 10252 | 0.020 |
Why?
|
| Random Allocation | 1 | 2011 | 2428 | 0.020 |
Why?
|
| Lung Neoplasms | 2 | 2008 | 13104 | 0.020 |
Why?
|
| Microvessels | 1 | 2011 | 544 | 0.020 |
Why?
|
| Stress, Mechanical | 1 | 2011 | 1686 | 0.020 |
Why?
|
| src-Family Kinases | 1 | 2009 | 551 | 0.020 |
Why?
|
| Boronic Acids | 1 | 2010 | 965 | 0.020 |
Why?
|
| Prevalence | 1 | 2003 | 15221 | 0.020 |
Why?
|
| Capillaries | 1 | 2009 | 773 | 0.020 |
Why?
|
| Statistics, Nonparametric | 1 | 2011 | 2887 | 0.020 |
Why?
|
| RNA, Messenger | 2 | 2011 | 13035 | 0.020 |
Why?
|
| Cell Transplantation | 1 | 2007 | 477 | 0.020 |
Why?
|
| Pulmonary Edema | 1 | 2008 | 414 | 0.020 |
Why?
|
| Pyrazines | 1 | 2010 | 1230 | 0.020 |
Why?
|
| Acetaminophen | 1 | 2008 | 545 | 0.010 |
Why?
|
| Cell Lineage | 1 | 2013 | 2504 | 0.010 |
Why?
|
| Mice, Nude | 1 | 2010 | 3689 | 0.010 |
Why?
|
| Base Sequence | 1 | 2014 | 12797 | 0.010 |
Why?
|
| Male | 7 | 2018 | 350118 | 0.010 |
Why?
|
| Down-Regulation | 1 | 2010 | 3001 | 0.010 |
Why?
|
| Tumor Cells, Cultured | 1 | 2010 | 6314 | 0.010 |
Why?
|
| Mice, Transgenic | 1 | 2014 | 9735 | 0.010 |
Why?
|
| Interleukin-2 | 1 | 2008 | 1904 | 0.010 |
Why?
|
| Molecular Sequence Data | 1 | 2014 | 18111 | 0.010 |
Why?
|
| RNA Interference | 1 | 2010 | 2891 | 0.010 |
Why?
|
| Epithelial Cells | 1 | 2011 | 3690 | 0.010 |
Why?
|
| Molecular Targeted Therapy | 1 | 2010 | 2726 | 0.010 |
Why?
|
| Cell Survival | 1 | 2009 | 5882 | 0.010 |
Why?
|
| Time Factors | 2 | 2011 | 40077 | 0.010 |
Why?
|
| Infant | 2 | 2010 | 35134 | 0.010 |
Why?
|
| Genotype | 1 | 2013 | 12952 | 0.010 |
Why?
|
| Dose-Response Relationship, Drug | 1 | 2010 | 10943 | 0.010 |
Why?
|
| Sensitivity and Specificity | 1 | 2011 | 14723 | 0.010 |
Why?
|
| DNA-Binding Proteins | 1 | 2013 | 9647 | 0.010 |
Why?
|
| Gene Expression Regulation, Neoplastic | 1 | 2010 | 8432 | 0.010 |
Why?
|
| Mice, Knockout | 1 | 2009 | 14561 | 0.010 |
Why?
|
| Risk Factors | 1 | 2020 | 72295 | 0.010 |
Why?
|
| Transcription Factors | 1 | 2013 | 12209 | 0.010 |
Why?
|
| Cell Line, Tumor | 1 | 2008 | 16692 | 0.010 |
Why?
|
| Infant, Newborn | 1 | 2010 | 25628 | 0.010 |
Why?
|
| Cell Differentiation | 1 | 2007 | 11486 | 0.010 |
Why?
|
| Child, Preschool | 1 | 2010 | 41005 | 0.000 |
Why?
|
| Child | 1 | 2010 | 77708 | 0.000 |
Why?
|
| Treatment Outcome | 1 | 2008 | 63115 | 0.000 |
Why?
|
Concepts
(212)
Derived automatically from this person's publications.
Explore
_
Co-Authors
(23)
People in Profiles who have published with this person.
Explore
_
Similar People
(60)
People who share similar concepts with this person.
Explore
_
Same Department
People in same department with this person.
Explore
_
Physical Neighbors
People whose addresses are nearby this person.
_